The aim of this study is to identify transcriptomic biomarkers in blood cells to diagnose early cognitive impairment. This would allow preventing the development of severe pathologies, such as Alzheimer Disease. In addition, this project will analyse the influence of adiposity, obesity, nutritional habits and physical activity on cognition.
Age range
55 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Percentage of semiquantitative gene expression of blood cells between the three groups
Timeframe: Baseline point (all groups)
Mini-Mental State Examination (MMSE), questionnaire (numerical scale)
Timeframe: Baseline point (all groups)
Montreal Cognitive Assessment (MoCA), questionnaire (numerical scale)
Timeframe: Baseline point (all groups)
Cognitive Reserve Questionnaire (CRIq), questionnaire (numerical scale)
Timeframe: Baseline point (all groups)
Body composition (fat mass)
Timeframe: Baseline point (all groups)